Antibiotic Injection Added to Drug Shortages List in New Update

December 7, 2018

The US Food and Drug Administration (FDA) recently added the anti-infective cefazolin injection to its FDA Drug Shortages database. The following providers are currently reporting shortages of the injection: Apotex Corp., B. Braun Medical, Hospira, Sagent Pharmaceuticals, Sandoz, West-Ward Pharmaceuticals, and WG Critical Care. An increase in demand was cited by several as the reason behind the shortage.

In other news, Merck Sharp & Dohme Corp. is discontinuing aprepitant (Emend) capsules, 40 mg, unit-of-use package of 1 (NDC 0006-0464-10) and unit-of-use package of 5 (NDC 0006-0464-05), according to the FDA databased update. The drug is used to prevent nausea and vomiting associated with chemotherapy and surgery.

Potassium chloride injection is now available in several forms from ICU Medical and Baxter Healthcare, according to the update. Hospira and Fresenius Kabi USA also have limited availability of the drug, which is used to prevent or treat low blood levels of potassium.

Sodium chloride 0.9% injection bags recently became available from ICU Medical, Fresenius Kabi USA, and Baxter Healthcare. Hospira has limited availability of the intravenous solution.

Sterile water is newly available from ICU Medical, Baxter Healthcare, and American Regent/Luitpold, according to the update. Hospira and Fresenius Kabi USA have limited availability.

For complete information on the shortages and discontinuation, visit the FDA website.

Jolynn Tumolo

For more Pharmacy Learning Network articles, visit the homepage